BackDecision Diagnostics Overview
Decision Diagnostics Corp.

Decision Diagnostics Return on Equity

Latest ROE for Decision Diagnostics: 16839.89% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

16839.89%

Return on Equity

16839.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Decision Diagnostics (DECN) FAQ

Decision Diagnostics's return on equity stands at 16839.89%. That is above the sector sector average of 11.3%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Decision Diagnostics sits higher the its sector benchmark (11.3%) with a ROE of 16839.89%. That is roughly 148975.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 16839.89% for Decision Diagnostics means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Decision Diagnostics's ROE evolved across reporting periods, while the comparison chart places DECN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers